Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × lenvatinib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 10 Carcinoma, Hepatocellular 10 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Endometrial Neoplasms 7 Uterine Cervical Neoplasms 4 Neoplasms 4 Thyroid Neoplasms 3 Liver Neoplasms 3 Cholangiocarcinoma 3 Adenocarcinoma 3 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Melanoma 2 Colorectal Neoplasms 2 Carcinoma, Transitional Cell 2 Biliary Tract Neoplasms 2 von Hippel-Lindau Disease 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma, Kaposi 1 Sarcoma 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Metastatic Castration-Resistant Prostate Cancer 1 Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer 1 Hematologic Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1

Interventions

Radiotherapy 11 Gemcitabine 7 Doxorubicin 7 Cyclophosphamide 7 pembrolizumab 6 Specimen Handling 6 Magnetic Resonance Spectroscopy 5 Biopsy 5 pazopanib 4 X-Rays 4 Trabectedin 4 Surgical Procedures, Operative 4 Radiation 4 Nivolumab 4 Ifosfamide 4 tazemetostat 3 talimogene laherparepvec 3 fludarabine 3 Temozolomide 3 Standard of Care 3 Phantoms, Imaging 3 Docetaxel 3 Blood Specimen Collection 3 selpercatinib 2 selinexor 2 regorafenib 2 olaparib 2 liposomal doxorubicin 2 ivosidenib 2 fludarabine phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07359053 2026-01-22

MAGNATE-S

Shanghai 6th People's Hospital

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡